WO2024009373A1 - Composition, procédé de sélection de composants dans une composition, procédé de production d'une composition, système de traitement d'informations et procédé de traitement d'informations - Google Patents
Composition, procédé de sélection de composants dans une composition, procédé de production d'une composition, système de traitement d'informations et procédé de traitement d'informations Download PDFInfo
- Publication number
- WO2024009373A1 WO2024009373A1 PCT/JP2022/026659 JP2022026659W WO2024009373A1 WO 2024009373 A1 WO2024009373 A1 WO 2024009373A1 JP 2022026659 W JP2022026659 W JP 2022026659W WO 2024009373 A1 WO2024009373 A1 WO 2024009373A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- intestinal environment
- effect
- expected
- component
- coverage rate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims description 36
- 230000010365 information processing Effects 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 238000003672 processing method Methods 0.000 title claims description 6
- 230000000694 effects Effects 0.000 claims abstract description 130
- 230000000968 intestinal effect Effects 0.000 claims description 162
- 239000004615 ingredient Substances 0.000 claims description 28
- 238000004364 calculation method Methods 0.000 claims description 11
- 238000010187 selection method Methods 0.000 claims description 2
- 238000003860 storage Methods 0.000 description 40
- 241000894006 Bacteria Species 0.000 description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
- 239000000126 substance Substances 0.000 description 30
- 235000013305 food Nutrition 0.000 description 25
- 235000013618 yogurt Nutrition 0.000 description 20
- 235000014655 lactic acid Nutrition 0.000 description 15
- 239000004310 lactic acid Substances 0.000 description 15
- 239000003814 drug Substances 0.000 description 12
- 239000013589 supplement Substances 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 7
- 239000002207 metabolite Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000605861 Prevotella Species 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000010794 food waste Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 241000203069 Archaea Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 description 1
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007637 random forest analysis Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Abstract
[Problème] Fournir une composition qui présente un rapport de couverture élevé d'un effet prescrit dans une population prescrite. [Solution] Une composition selon la présente invention contient deux composants ou plus présentant un effet prescrit et permet à chacun des composants d'être sélectionné de telle sorte que la somme des rapports de couverture qui indiquent la proportion de sujets dans une population prescrite pour laquelle l'effet peut être attendu est supérieure ou égale à une proportion prescrite.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2022/026659 WO2024009373A1 (fr) | 2022-07-05 | 2022-07-05 | Composition, procédé de sélection de composants dans une composition, procédé de production d'une composition, système de traitement d'informations et procédé de traitement d'informations |
| JP2023501580A JP7336168B1 (ja) | 2022-07-05 | 2022-07-05 | 組成物、組成物における成分の選択方法、組成物の製造方法、情報処理システムおよび情報処理方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2022/026659 WO2024009373A1 (fr) | 2022-07-05 | 2022-07-05 | Composition, procédé de sélection de composants dans une composition, procédé de production d'une composition, système de traitement d'informations et procédé de traitement d'informations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024009373A1 true WO2024009373A1 (fr) | 2024-01-11 |
Family
ID=87764088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2022/026659 WO2024009373A1 (fr) | 2022-07-05 | 2022-07-05 | Composition, procédé de sélection de composants dans une composition, procédé de production d'une composition, système de traitement d'informations et procédé de traitement d'informations |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7336168B1 (fr) |
| WO (1) | WO2024009373A1 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204355A (ja) * | 2014-09-10 | 2016-12-08 | 日環科学株式会社 | プロバイオティクス、あるいはプレバイオティクス、並びにその製造方法、微生物製剤、健康食品並びに医薬品 |
| JP2018049645A (ja) * | 2015-08-12 | 2018-03-29 | ヤヱガキ醗酵技研株式会社 | 情報処理装置、情報処理方法、及びプログラム |
-
2022
- 2022-07-05 WO PCT/JP2022/026659 patent/WO2024009373A1/fr unknown
- 2022-07-05 JP JP2023501580A patent/JP7336168B1/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204355A (ja) * | 2014-09-10 | 2016-12-08 | 日環科学株式会社 | プロバイオティクス、あるいはプレバイオティクス、並びにその製造方法、微生物製剤、健康食品並びに医薬品 |
| JP2018049645A (ja) * | 2015-08-12 | 2018-03-29 | ヤヱガキ醗酵技研株式会社 | 情報処理装置、情報処理方法、及びプログラム |
Non-Patent Citations (3)
| Title |
|---|
| ANONYMOUS: "How would you classify people around the world based on their intestinal bacteria types? | Interesting stories about the intestines Part 1 ", SUNSTAR HEALTH DOJO, 28 October 2020 (2020-10-28), pages 1 - 4, XP093124672, Retrieved from the Internet <URL:https://www.kenkodojo.com/guts/detail1/> * |
| ANONYMOUS: "MG Diet Support (for companies) <br> ~ Utilize AI! Weight loss support program that takes into account intestinal environment type", METAGEN CO., LTD., 2 September 2022 (2022-09-02), XP093124666, Retrieved from the Internet <URL:https://metagen.co.jp/service/biz-dev/mgdietsupport/> [retrieved on 20240129] * |
| ANONYMOUS: "What are the characteristics of Japanese intestinal bacteria? Why are they different from those in the United States and China?", ASAHI SHIMBUN COMPANY, 28 April 2021 (2021-04-28), XP093124674, Retrieved from the Internet <URL:https://www.asahi.com/relife/article/14339144> [retrieved on 20240129] * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7336168B1 (ja) | 2023-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zickgraf et al. | Initial validation of the Nine Item Avoidant/Restrictive Food Intake disorder screen (NIAS): A measure of three restrictive eating patterns | |
| Eaton et al. | Effectiveness of provision of animal‐source foods for supporting optimal growth and development in children 6 to 59 months of age | |
| Tuddenham et al. | The intestinal microbiome and health | |
| Laursen et al. | Infant gut microbiota development is driven by transition to family foods independent of maternal obesity | |
| Golley et al. | Motivations for avoiding wheat consumption in Australia: results from a population survey | |
| De Filippo et al. | Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa | |
| Shikany et al. | Association of dietary patterns with the gut microbiota in older, community-dwelling men | |
| Hascoët et al. | Effect of formula composition on the development of infant gut microbiota | |
| Savy et al. | Are dietary diversity scores related to the socio-economic and anthropometric status of women living in an urban area in Burkina Faso? | |
| Kontogianni et al. | A high polyphenol diet improves psychological well-being: The polyphenol intervention trial (pphit) | |
| Ramin et al. | A prospective analysis of dietary fiber intake and mental health quality of life in the Iowa Women’s Health Study | |
| Berding et al. | Dietary patterns impact temporal dynamics of fecal microbiota composition in children with autism spectrum disorder | |
| Fiese et al. | The Strong Kids 2 birth cohort study: A cell-to-society approach to dietary habits and weight trajectories across the first 5 years of life | |
| Mari-Bauset et al. | Anthropometric measurements and nutritional assessment in autism spectrum disorders: A systematic review | |
| Lee et al. | Relationship between dietary intakes and the double burden of malnutrition in adults of Malang, Indonesia: An exploratory study | |
| Zulkifli et al. | Relationships Between Sensory Processing Disorders With Feeding Behavior Problems Among Children With Autism Spectrum Disorder. | |
| Silvi et al. | Probiotic-enriched foods and dietary supplement containing SYNBIO positively affects bowel habits in healthy adults: an assessment using standard statistical analysis and Support Vector Machines | |
| Hajizadeh et al. | Dietary habits and personal care product use as predictors of urinary concentrations of parabens in Iranian adolescents | |
| Matsuoka et al. | Relationships between barley consumption and gut microbiome characteristics in a healthy Japanese population: a cross-sectional study | |
| Costantini et al. | Effect of die configuration on the physico-chemical properties, anti-nutritional compounds, and sensory features of legume-based extruded snacks | |
| Mathew et al. | Dietary intake in children on the autism spectrum is altered and linked to differences in autistic traits and sensory processing styles | |
| Loncar et al. | Associations of parenting factors and weight related outcomes in African American adolescents with overweight and obesity | |
| Łopusiewicz et al. | Effect of Flaxseed Oil Cake Extract on the Microbial Quality, Texture and Shelf Life of Gluten-Free Bread | |
| Lunken et al. | Variability in gut microbiota response to an inulin-type fructan prebiotic within an in vitro three-stage continuous colonic model system | |
| Rudolph et al. | A pilot study assessing the impact of a fortified supplementary food on the health and well-being of crèche children and adult TB patients in South Africa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22950167 Country of ref document: EP Kind code of ref document: A1 |